DSGN vs UAL · $214.0M cap vs P/E 10, rev $32.28B
Design Therapeutics Inc (DSGN) versus United Airlines Holdings Inc (UAL) — a side-by-side from cached financials, not a winner call.
Design Therapeutics Inc (DSGN) is a biotechnology company listed on US.
United Airlines Holdings Inc (UAL) is a airlines company listed on NASDAQ. It is led by Scott Kirby.
Latest reported DSGN revenue for 2026-06-30 was $0. Net income was -$37.8M. DSGN currently screens at market cap $214.0M.
Latest reported UAL revenue for 2026-06-30 was $32.28B. Net income was $1.50B. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
DSGN currently screens at market cap $214.0M. UAL currently screens at market cap $37.59B and trailing P/E 10.4.
Not investment advice. Open the DSGN and UAL stock pages for the full models.
Not investment advice.